Ali Jafarizadeh, MD
Ophthalmology — Tabriz University of Medical Sciences, Iran
Ali Jafarizadeh
LeadR Profile
Ophthalmology
Subspecialties: Oncology - Neurology - Informatics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Ali Jafarizadeh, MD, MPH, is a physician-scientist with a strong interest in ophthalmology, medical research, artificial intelligence, and biostatistics. His research focuses on integrating AI and advanced retinal imaging with clinical and epidemiological data to improve the detection, prediction, and management of ocular and systemic diseases. He is particularly passionate about retinal imaging biomarkers, ophthalmic imaging, machine learning, deep learning, and evidence-based clinical research. His research experience spans clinical studies, epidemiology, systematic reviews and meta-analyses, and AI-driven medical imaging projects, with collaborations across international research groups. He has authored and co-authored peer-reviewed publications in ophthalmology and AI in healthcare. He was also recognised as a Distinguished Medical Student at the 62nd Annual Alborz Award for scientific excellence.
Organizations
Career arc: 2022 - 2026
Number : 43
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Ocular findings in pediatric candidates for cochlear implantation with bilateral sensorineural hearing loss: a brief report from northwestern Iran. hearing, refractive errors, hearing loss, sensorineural, prevalence, eye diseases, hearing loss, cochlear implantation | BMC Ophthalmol | 2026 | 0 |
| Is Current Evidence Sufficient to Establish the Efficacy of Botulinum Toxin A in Treating Persistent Dry Eye Disease? A Systematic Review and Meta-Analysis of Interventional Studies With a Critical Review Using GRADE Tool. eye, spasm, tears, botulinum toxins, type a, botulinum toxins, eye diseases, dry eye syndromes | Health Sci Rep | 2026 | 0 |
| Re: 'The effect of botulinum toxin A on dry eye disease and syndromes'. eye, botulinum toxins, type a, botulinum toxins, eye diseases, dry eye syndromes | Clin Exp Optom | 2026 | 0 |
| Botulinum toxin a for dry eye disease: impact of population mixing and statistical issues. eye, ophthalmology, botulinum toxins, type a, botulinum toxins, eye diseases, dry eye syndromes | Eye (Lond) | 2026 | 0 |
| Memantine, an NMDA Receptor Antagonist, Attenuates Doxorubicin-Induced Cardiac Oxidative Stress and Inflammation in Mouse 4T1 Breast Cancer Model. cells, receptors, n-methyl-d-aspartate, breast neoplasms, stress, physiological, doxorubicin, neoplasms, drug therapy, oxidative stress, cell line, breast, cardiotoxicity, therapeutics, tissues, memantine, chemotherapy | Breast Cancer (Auckl) | 2025 | 0 |
LeadR Networks
Main global connection map